Browse Drug Recalls
1,301 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,301 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,301 FDA drug recalls in IL.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 3, 2021 | Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Sep 3, 2021 | Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, M... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Sep 3, 2021 | Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, ... | Failed Impurities/Degradation Specifications | Class III | Meitheal Pharmaceuticals Inc |
| Sep 3, 2021 | AMINOSYN II 15% An Amino Acid Injection, Sulfite-Free, 2000 mL in flexible co... | Presence of Particulate Matter: Particulate matter identified as fibers, hair, and proteinaceous ... | Class I | ICU Medical Inc |
| Sep 3, 2021 | Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/... | CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contamin... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Aug 13, 2021 | Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 m... | Failed impurities/degradation specification: Out of Specification for an unknown impurity observe... | Class II | Akorn, Inc. |
| Aug 6, 2021 | Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For... | Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does ... | Class II | XELLIA PHARMACEUTICALS USA, LLC |
| Aug 6, 2021 | Micafungin for Injection, 100 mg/vial, Single-Dose Vial, Sterile, Rx Only, Fo... | Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does ... | Class II | XELLIA PHARMACEUTICALS USA, LLC |
| Aug 2, 2021 | Artificial Tears Ointment, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) pe... | Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stabil... | Class II | Akorn, Inc. |
| Jun 25, 2021 | Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Inje... | Low out of specification results for epinephrine assay. | Class II | Fresenius Kabi USA LLC |
| May 14, 2021 | READYPREP CHG, 2% Chlorhexidine Gluconate Cloth, 2 9x10.5 in (22.9x26.7 cm) D... | Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate. | Class III | Medline Industries Inc |
| May 3, 2021 | 1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose v... | Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, U... | Class I | PFIZER, INC |
| May 3, 2021 | 0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL ... | Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, U... | Class I | PFIZER, INC |
| May 3, 2021 | Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 2... | Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 co... | Class III | Mylan Institutional LLC |
| Mar 11, 2021 | Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial pac... | Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may res... | Class II | Sagent Pharmaceuticals Inc |
| Mar 10, 2021 | aulief (Organic Camphor 3.00% Organic Menthol 5.00%), topical pain relief, pa... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | CHINA_GEL (Camphor 3.00%, Menthol 5.00%) A TOPICAL PAIN RELIEVER, packaged as... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | CHINA-GEL WHITE (Camphor 3.00%, Menthol 5.00%), A TOPICAL PAIN RELIEVER, pack... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 9, 2021 | 0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manu... | Presence of particulate matter.one confirmed customer report of particulate matter within two se... | Class II | ICU Medical Inc |
| Mar 8, 2021 | Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose... | Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed ... | Class II | Akorn, Inc. |
| Mar 2, 2021 | Acetaminophen, Extra Strength, Aspirin Free, 500 MG Tablets, 100-count bottle... | Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 co... | Class I | A-S Medication Solutions LLC. |
| Jan 27, 2021 | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dos... | Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain t... | Class I | Meitheal Pharmaceuticals Inc |
| Jan 1, 2021 | Chlorhexidine Gluconate Oral Rinse USP 0.12%, packaged in a) 15 mL x 30 Unit ... | cGMP deviations: The firm was notified of the manufacturer's expanded recall. | Class II | Precision Dose Inc. |
| Dec 28, 2020 | Levetiracetam Oral Solution, 100 mg/mL, 16 fl oz (473 mL) bottle, Rx Only, HI... | Defective container: Customer complaints for oral solution leaking from bottles. | Class II | Akorn, Inc. |
| Dec 28, 2020 | Paroex (Chlorhexidine Gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only... | cGMP Deviations; FDA inspection of manufacturing facility observed potential Burkholderia cepacia... | Class II | Sunstar Americas, Inc. |
| Dec 23, 2020 | Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single ... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class I | Fresenius Kabi USA, LLC |
| Dec 17, 2020 | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), package... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class II | Fresenius Kabi USA, LLC |
| Dec 10, 2020 | Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 m... | Subpotent Drug: Low out-of-specification assay results for the epinephrine component. | Class II | Fresenius Kabi USA, LLC |
| Dec 9, 2020 | Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in... | Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, ... | Class II | Morton Grove Pharmaceuticals, Inc. |
| Nov 17, 2020 | Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg... | Cross Contamination with other products: trace amounts of lidocaine | Class I | Fresenius Kabi USA, LLC |
| Nov 17, 2020 | DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill... | Cross Contamination with Other Products: trace amounts of octreotide found during testing | Class III | Fresenius Kabi USA, LLC |
| Oct 27, 2020 | Paroex (chlorhexidine gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only... | Microbial Contamination of Non-sterile Products: contamination with Burkholderia lata. | Class I | Sunstar Americas, Inc. |
| Oct 7, 2020 | Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 m... | Presence of particulate matter in solution - black and transparent particles | Class II | Baxter Healthcare Corporation |
| Sep 3, 2020 | Eye Itch Relief, Ketotifen Fumarate Ophthalmic Solution 0.035%, Sterile, 5 mL... | CGMP Deviations | Class II | Akorn, Inc. |
| Aug 17, 2020 | Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-... | Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contai... | Class I | Mylan Institutional LLC |
| Aug 17, 2020 | Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose ... | Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contai... | Class I | Mylan Institutional LLC |
| Jul 22, 2020 | Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 m... | Cross Contamination with other products: trace amounts of lidocaine | Class I | Fresenius Kabi USA, LLC |
| Jul 13, 2020 | Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx on... | Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly sta... | Class III | Fresenius Kabi USA, LLC |
| Jul 7, 2020 | Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Ma... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Jun 5, 2020 | Prednisolone Sodium Phosphate Oral Solution, 5 mg/5 mL, 120 mL Bottle, Rx onl... | Discoloration: Out of Specification (OOS) result for APHA Color Test. | Class III | Akorn, Inc. |
| May 8, 2020 | LACTATED RINGER'S Injection, USP 1000 mL flexible container, Rx Only, Hospira... | Presence of Particulate Matter: confirmed customer complaint for the presence of particulate matt... | Class I | ICU Medical Inc |
| May 5, 2020 | Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only,... | Discoloration: Out-of-specification results for appearance obtained during routine stability test... | Class II | Mylan Institutional LLC |
| Apr 20, 2020 | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), package... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class II | Fresenius Kabi USA, LLC |
| Apr 20, 2020 | Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single ... | Presence of Particulate Matter - found in reserve sample vials at the firm. | Class I | Fresenius Kabi USA, LLC |
| Mar 25, 2020 | Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per car... | Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.... | Class III | Akorn Inc |
| Feb 21, 2020 | Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: A... | Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identi... | Class III | Akorn, Inc. |
| Feb 21, 2020 | CVS Health Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distribu... | Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identi... | Class III | Akorn, Inc. |
| Feb 21, 2020 | Well at Walgreens Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, D... | Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identi... | Class III | Akorn, Inc. |
| Dec 26, 2019 | Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper ... | Chemical contamination; out of specification results obtained for equipment cleaning residue rins... | Class III | Akorn, Inc. |
| Dec 16, 2019 | NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 ... | Subpotent Drug | Class III | Pharmedium Services, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.